Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $69.7 million.

  • Cellebrite DI's Total Non-Current Liabilities rose 2018.1% to $69.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.7 million, marking a year-over-year increase of 2018.1%. This contributed to the annual value of $59.0 million for FY2024, which is 7588.51% down from last year.
  • Per Cellebrite DI's latest filing, its Total Non-Current Liabilities stood at $69.7 million for Q3 2025, which was up 2018.1% from $69.0 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Total Non-Current Liabilities registered a high of $359.5 million during Q2 2024, and its lowest value of $41.4 million during Q3 2021.
  • For the 5-year period, Cellebrite DI's Total Non-Current Liabilities averaged around $153.6 million, with its median value being $127.9 million (2022).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 46644.91% in 2021, then tumbled by 8175.73% in 2025.
  • Quarter analysis of 5 years shows Cellebrite DI's Total Non-Current Liabilities stood at $226.6 million in 2021, then tumbled by 46.3% to $121.7 million in 2022, then surged by 101.27% to $244.8 million in 2023, then plummeted by 75.89% to $59.0 million in 2024, then rose by 18.07% to $69.7 million in 2025.
  • Its last three reported values are $69.7 million in Q3 2025, $69.0 million for Q2 2025, and $58.6 million during Q1 2025.